Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults : a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)
Citation
Pickard , R , Starr , K , MacLennan , G , Kilonzo , M , Lam , T , Thomas , R E , Burr , J , Norrie , J , McPherson , G , McDonald , A , Shearer , K , Gillies , K , Anson , K , Boachie , C , N'Dow , J , Burgess , N , Clark , T , Cameron , S & McClinton , S 2015 , ' Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults : a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial) ' , Health Technology Assessment , vol. 19 , no. 63 , pp. 1-171 . https://doi.org/10.3310/hta19630